Literature DB >> 8845753

Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

C Abad-Zapatero1, R Goldman, S W Muchmore, C Hutchins, K Stewart, J Navaza, C D Payne, T L Ray.   

Abstract

The three-dimensional structure of a secreted aspartic protease from Candida albicans complexed with a potent inhibitor reveals variations on the classical aspartic protease theme that dramatically alter the specificity of this class of enzymes. The structure presents: (1) an 8-residue insertion near the first disulfide (Cys 45-Cys 50, pepsin numbering) that results in a broad flap extending toward the active site; (2) a 7-residue deletion replacing helix hN2 (Ser 110-Tyr 114), which enlarges the S3 pocket; (3) a short polar connection between the two rigid body domains that alters their relative orientation and provides certain specificity; and (4) an ordered 11-residue addition at the carboxy terminus. The inhibitor binds in an extended conformation and presents a branched structure at the P3 position. The implications of these findings for the design of potent antifungal agents are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845753      PMCID: PMC2143388          DOI: 10.1002/pro.5560050408

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  40 in total

Review 1.  The structure and function of the aspartic proteinases.

Authors:  D R Davies
Journal:  Annu Rev Biophys Biophys Chem       Date:  1990

2.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes.

Authors:  J W Ponder; F M Richards
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

3.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO.

Authors:  T A Jones
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

4.  Comparative production and rapid purification of Candida acid proteinase from protein-supplemented cultures.

Authors:  T L Ray; C D Payne
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

5.  The three-dimensional structure of recombinant bovine chymosin at 2.3 A resolution.

Authors:  G L Gilliland; E L Winborne; J Nachman; A Wlodawer
Journal:  Proteins       Date:  1990

Review 6.  Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis.

Authors:  R C Goldman; D J Frost; J O Capobianco; S Kadam; R R Rasmussen; C Abad-Zapatero
Journal:  Infect Agents Dis       Date:  1995-12

7.  A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.

Authors:  D Bailey; J B Cooper
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

8.  The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members.

Authors:  B B Magee; B Hube; R J Wright; P J Sullivan; P T Magee
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.

Authors:  G Bolis; A K Fung; J Greer; H D Kleinert; P A Marcotte; T J Perun; J J Plattner; H H Stein
Journal:  J Med Chem       Date:  1987-10       Impact factor: 7.446

Review 10.  Comparative modeling of proteins in the design of novel renin inhibitors.

Authors:  C Hutchins; J Greer
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

View more
  9 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Protease expression by microorganisms and its relevance to crucial physiological/pathological events.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2011-03-26

Review 3.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

4.  Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.

Authors:  H C Korting; M Schaller; G Eder; G Hamm; U Böhmer; B Hube
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

5.  HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2010-02-26

Review 6.  Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Authors:  Julian R Naglik; Stephen J Challacombe; Bernhard Hube
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

7.  Evidence that the Bacillus subtilis SpoIIGA protein is a novel type of signal-transducing aspartic protease.

Authors:  Daisuke Imamura; Ruanbao Zhou; Michael Feig; Lee Kroos
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

8.  Extensive expansion of A1 family aspartic proteinases in fungi revealed by evolutionary analyses of 107 complete eukaryotic proteomes.

Authors:  María V Revuelta; Jan A L van Kan; John Kay; Arjen Ten Have
Journal:  Genome Biol Evol       Date:  2014-06       Impact factor: 3.416

9.  Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.

Authors:  Magdalena Rudzińska; Cenk Daglioglu; Lyudmila V Savvateeva; Fatma Necmiye Kaci; Rodolphe Antoine; Andrey A Zamyatnin
Journal:  Drug Des Devel Ther       Date:  2021-01-06       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.